While the safety of GLP-1 drugs in people with lupus is still under study, there are several potential benefits that could make them an appealing option for those with coexisting conditions, such as diabetes or obesity
While sublingual preparations contain very low doses (50100 mg), oral suspensions and solutions have a foul sulfurous taste and need to be freshly prepared
At week 13, significant, dose-dependent reductions in HbA 1c (the primary endpoint) were reported [10]
PlexusDx makes precision GLP-1 therapy accessible by offering compounded medications from licensed 503A pharmacies nationwide, with no insurance requirement, no membership fees, and transparent pricing that stays consistent regardless of your dose
Indian J Urol 35(1):18-24
Management of cardiovascular diseases by short-chain fatty acid postbiotics